Milestone Earnings Yield from 2010 to 2024

MIST Stock  USD 1.54  0.01  0.65%   
Milestone Pharmaceuticals Earnings Yield yearly trend continues to be comparatively stable with very little volatility. Earnings Yield is likely to outpace its year average in 2024. Earnings Yield is the inverse of the price-to-earnings ratio, representing the percentage of each dollar invested in the stock that was earned by the company. View All Fundamentals
 
Earnings Yield  
First Reported
2010-12-31
Previous Quarter
(0.83)
Current Value
(0.79)
Quarterly Volatility
0.27278778
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Milestone Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Milestone Pharmaceuticals' main balance sheet or income statement drivers, such as Tax Provision of 0.0, Net Interest Income of 1.2 M or Interest Income of 3.7 M, as well as many indicators such as Price To Sales Ratio of 75.32, Dividend Yield of 0.0 or PTB Ratio of 4.49. Milestone financial statements analysis is a perfect complement when working with Milestone Pharmaceuticals Valuation or Volatility modules.
  
Check out the analysis of Milestone Pharmaceuticals Correlation against competitors.
For more information on how to buy Milestone Stock please use our How to Invest in Milestone Pharmaceuticals guide.

Latest Milestone Pharmaceuticals' Earnings Yield Growth Pattern

Below is the plot of the Earnings Yield of Milestone Pharmaceuticals over the last few years. It is the inverse of the price-to-earnings ratio, representing the percentage of each dollar invested in the stock that was earned by the company. Milestone Pharmaceuticals' Earnings Yield historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Milestone Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
Earnings Yield10 Years Trend
Slightly volatile
   Earnings Yield   
       Timeline  

Milestone Earnings Yield Regression Statistics

Arithmetic Mean(0.19)
Coefficient Of Variation(144.49)
Mean Deviation0.20
Median(0.02)
Standard Deviation0.27
Sample Variance0.07
Range0.8098
R-Value(0.79)
Mean Square Error0.03
R-Squared0.62
Significance0.0005
Slope(0.05)
Total Sum of Squares1.04

Milestone Earnings Yield History

2024 -0.79
2023 -0.83
2022 -0.34
2021 -0.16
2020 -0.25
2019 -0.22
2018 -0.0638

About Milestone Pharmaceuticals Financial Statements

Milestone Pharmaceuticals shareholders use historical fundamental indicators, such as Earnings Yield, to determine how well the company is positioned to perform in the future. Although Milestone Pharmaceuticals investors may analyze each financial statement separately, they are all interrelated. The changes in Milestone Pharmaceuticals' assets and liabilities, for example, are also reflected in the revenues and expenses on on Milestone Pharmaceuticals' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Earnings Yield(0.83)(0.79)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Milestone Stock Analysis

When running Milestone Pharmaceuticals' price analysis, check to measure Milestone Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Milestone Pharmaceuticals is operating at the current time. Most of Milestone Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Milestone Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Milestone Pharmaceuticals' price. Additionally, you may evaluate how the addition of Milestone Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.